期刊文献+

ACEI联合小剂量安体舒通对左室重构和胶原更新的影响 被引量:2

The effects of ACEI and a low dose of spironolactone on the left ventricular remodeling and the turnover of myocardial collagen
下载PDF
导出
摘要 目的 :观察ACEI加安体舒通对心脏胶原更新和左室重量的影响。方法 :临床研究随机入选原发性高血压患者 135人 ,随机分入A(ACEI+安体舒通 )、B(ACEI)、C (非RAAS干预治疗 )三组 ,同等控制血压 ,观察 1年 ,比较 3种治疗方案对心肌胶原更新和左室重量的影响。结果 :临床研究显示在同等控制血压的前提下 ,减低血清PⅢNP的疗效及减低左室重量指数 ,ACEI联合抗醛固酮治疗优于单纯ACEI治疗 ,优于非RAAS干预治疗。结论 :原发性高血压患者应用ACEI联合抗醛固酮治疗比单纯ACEI治疗更好的减低血清PⅢNP和左室重量指数 ,并使心肌间质胶原沉积明显减低 。 Objective:To observe the effects on collagen turnover and the relationship between PⅢNP and remedy,PⅢNP and left ventricular remodeling by controlling the angiotensin II and aldosteron of RAAS under the premise of controlling blood pressure stably and efficiently. Methods: 135 patients with hypertension were observed for one year. All of them were divided into three groups randomly,including A (ACEI+spironolactone), B (ACEI) and C (traditional remedy: intervention with routine therapeutics excluding the drugs effecting on RAAS) groups. The serum PⅢNP and the left ventricular weight index (LVWI) were compared before and after the therapy. Results:Under the same blood pressure controlling precondition,the remedy of a low dose of spironolactone along with ACEI can decrease serum PⅢNP and LVWI much more. The remedy of ACEI with a low dose of spironolactone is correlated with the decrease of serum PⅢNP and LVWI. Conclusion:The remedy of a low dose of spironolactone along with ACEI is better in the decreasing of serum PⅢNP,the myocardial interstitial collagen deposition,and the left ventricular remodeling than ACEI remedy and traditional remedy. This effect is independent on blood pressure control.
出处 《军医进修学院学报》 CAS 2004年第3期164-166,共3页 Academic Journal of Pla Postgraduate Medical School
基金 "十五"军队科研基金资助项目 (0 1Q0 5 6)
关键词 ACEI 小剂量 安体舒通 左室重构 胶原更新 原发性高血压 心肌肥厚 aldosterone fibrosis,myocardium collagen PⅢNP(three type procollagen amino terminal peptide) left ventricular weight index (LVWI)
  • 相关文献

参考文献10

  • 1Hess OM,State of the art:current treatment of heart failure [J],Europ Heart J,2000,2 (Suppl A):A13-16. 被引量:1
  • 2Ferrari R The harmful effects of aldosterone in heart failure [J],Europ Heart J,2000,2 (Suppl A):A6-12. 被引量:1
  • 3Hobbs RE,Results of the ATLAS study-High or low doses of ACE inhibitors for heart failure [J] ? Clev Clin J Med,1998,65:539-542. 被引量:1
  • 4Sato A,Suzuki Y,Saruta T,Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension [J],Hypertens Res,1999,22(1):17-22. 被引量:1
  • 5Mayer IV,Fischer A,Jakob M,et al,Reversal of increased diastolic stiffness in mitral stenosis after successful balloon valvuloplasty [J],J Heart Valve Dis,1999,8(1):47-56. 被引量:1
  • 6Cohn JN,From hypertension to heart failure [J],Eur Heart J(Suppl) 2000,2(Suppl A):A2-A5. 被引量:1
  • 7Zannad F,Dousset B,Alla F,Zannad F,Dousset B,Alla F,Treatment of congestive heart failure:interfering the aldosterone-cardiac extracellular matrix relationship [J],Hypertension,2001,38 (5):1227-1232. 被引量:1
  • 8Pitt B,for the RALES Investigators,The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J],N Eng1 J Med,1999,341:2709-2717. 被引量:1
  • 9Pieske B,Hasenfuss G,Pathophysiological basis of heart failure [J],Ther Umsch,2000,57(5):284-292. 被引量:1
  • 10Heart Outcome Prevention Evaluation (HOPE) Study Investigation,Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients [J],N Engl J Med,2000,342:145-153. 被引量:1

同被引文献24

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部